By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Shire Pharmaceuticals 

725 Chesterbrook Boulevard

Wayne  Pennsylvania  19087-5637  U.S.A.
Phone: 484-595-8800 Fax: 484-595-8900


SEARCH JOBS

There’s a simple purpose that sits at the heart of our business: to enable people with life-altering conditions to lead better lives. This means we focus on developing treatments for conditions where the impact of our medicines can make an immediate and tangible difference for patients.

Our growth strategy is to focus on developing and marketing innovative specialty medicines for symptomatic conditions to meet significant unmet patient needs. Our two strategic priorities are to drive optimum performance of our existing products, enabling access to these medicines for patients today; and building our pipeline through research and development (R&D) and business development (BD), delivering access in the future for patients

We are always looking for talented people to join the Shire team. To learn more about Shire, visit www.shire.com. For more information on career opportunities with Shire, please visit: www.TimeToBeBrave.com .

Shire. To be as brave as the people we help.


Key Statistics


Email:
Ownership: Public

Web Site: Shire Pharmaceuticals
Employees: 336
Symbol: SHPG
 



Industry
Pharmaceutical






Company News
Shire Delivers Record Quarterly Revenues And Non GAAP Diluted Earnings Per ADS Up 42%. 7/18/2014 8:14:55 AM
AbbVie (ABBV) Finally Clinches Shire For $54 Billion 7/18/2014 6:53:49 AM
Federal Trade Commission Urged To Probe Shire, Sanofi (France) (SAN.PA) & Icahn Med School Over A "Conspiracy" 7/16/2014 6:44:55 AM
Shire Release: Vyvanse: This Time I'll be Bulletproof 6/25/2014 9:51:37 AM
Shire Pharmaceuticals (SHPG) Release: We Believe The Bids Could Go Higher, Or A Different Currency Is Required 6/25/2014 9:24:02 AM
Shire Pharmaceuticals (SHPG) Release: Vyvanse® Patents Found To Be Infringed And Valid By U.S. District Court 6/25/2014 6:32:20 AM
AbbVie (ABBV) Release: Shire Bid Could Move A Lot High Risk Puts Ceiling At £55/Share 6/23/2014 12:47:46 PM
Shire plc Release: Management Spurns Three Offers From AbbVie (ABBV) , Fighting For Irish Independence, Call Monday Morning 6/23/2014 12:42:43 PM
Shire plc Release: The Path To US$10 Billion In Product Sales By 2020 6/23/2014 9:35:21 AM
Shire Pharmaceuticals (SHPG) To Participate At The Goldman, Sachs & Co. 35th Annual Global Healthcare Conference 6/10/2014 7:51:33 AM
12345678910...
//-->